This agent used for clinical depression probably is not viable for use as a specific GRK2 inhibitor but is a great starting point for chemistry to develop novel GRK2 inhibitors that can be used eventually for cardiovascular disorders. The gene discussed is GRK2; the disease is major depressive disorder.